New additions to lineup include two original
cultivars from Aurora's breeding program, strain-specific gummies,
aromatic vapes and terpy diamonds & sauce
EDMONTON, AB, April 25,
2023 /PRNewswire/ - Aurora Cannabis (NASDAQ: ACB)
(TSX: ACB), the Canadian company opening the world to cannabis,
today announced a fresh lineup of innovative products. Coming soon
to patients at Aurora Medical and to consumers at retail stores
across the country, the company's expanded portfolio includes newly
developed cultivars, strain-specific gummies and aromatic vapes.
Flower products include two original strains from Occo, Aurora's
esteemed breeding program: Pink Diesel '71 and
Moon Berry.
"We're delighted to unveil the latest additions to our
ever-evolving portfolio of products," says Lana Culley, Vice President of Product
Development at Aurora Cannabis. "Our R&D team is focused on
developing new products that capture the essence of what our
patients and consumers value most – high quality and consistent
cannabis in a wide variety of formats. Our spring lineup delivers
on that and builds upon our total portfolio of Aurora
products."
Through Aurora's best-in-class genetics breeding program, backed
by extensive consumer research and development, Aurora continues to
focus on expanding its portfolio of product offerings, while
developing unique cultivars and formats that appeal to a wide
variety of patients and consumers.
New products launching this April include:
San Rafael '71:
- Pink Diesel '71 (3.5g & 14g flower, 3 x 0.5g pre-rolls) – A
premium strain crossbred from two of San Rafael '71's most popular
cultivars, Pink Kush and Driftwood Diesel. The result is a pungent,
powerful and 100% original indica with notes of gas, lavender and
spice, delivering 24-30% THC. Hang-dried, hand-finished and
hand-bottled for an excellent final product.
- Moon Berry (3.5g & 14g
flower, 3 x 0.5g pre-rolls) – A premium strain with a balanced 1:1
ratio of THC to CBD, Moon Berry has
a delightful aroma of berries, cream and lemon. Bred from Aurora
Medical's Vespera and Equiposa cultivars, Moon Berry is a great choice for those looking
for a full-flavoured experience with moderate THC and balanced
CBD.
- Tangerine Dream Cured Resin Gummies (4 x 2.5mg) – Made with
strain-specific cured resin from premium dried flower extracted
using Aurora's state-of-the-art hydrocarbon process. These sativa
gummies have a sweet citrus, tangerine flavour inspired by the
character of the flower.
Greybeard:
- DJ Melon Live Resin Diamonds & Sauce (1g) – Named after a
unique formulation that combines KISH and AFD live resins,
resulting in a melon-y aroma, DJ Melon is 99.9% THCa Diamonds
smothered in a sweet terp sauce that evokes light citrus notes with
subtle hints of pine.
- Pineapple M Live Resin Diamonds & Sauce (1g) – Boasted a
rich fuel and pineapple aroma, Pineapple M is 99.9% THCa Diamonds
smothered in a sweet and gassy terp sauce. This limited time offer
is made with our award-winning hydrocarbon extract process.
- Slymer Live Resin Vape (510 - 1g) – Made from 100% pure live
resin, Slymer is named for its abundant trichome production and
exceptional pine and lemon aroma for a fresh and invigorating
true-to-strain experience.
- Trufflez Live Resin Vape (510 – 1g) – With an ultra-gassy,
savoury and earthy aroma profile, Trufflez is made from 100% pure
live resin.
Whistler Cannabis Co.:
- Organic BC Rockstar (28g flower) – One of our best-selling
strains of all time is now available in a 28g format, for a limited
time only. Bred from a cross of Rockstar and Bubba Kush cultivars, BC Rockstar is a
hard-hitting indica with earthy and piney notes. Delivering 20-27%
THC, this flower is grown in living soil with a small-batch
approach.
Daily Special
- Mondo Grape XL Vape (510 - 1g) - Delivering big grape flavour,
this vape is made with a proprietary resin blend, enhanced with
botanical terpenes for a broad-spectrum, full-flavour
experience.
The spring product release is set to roll out to patients on
Aurora Medical and in adult-use retailers starting in April.
Select products are available in certain regions.
About Aurora:
Aurora is opening the world to cannabis, serving both the
medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis, dedicated to helping people improve their lives.
The Company's adult-use brand portfolio includes Aurora Drift, San
Rafael '71, Daily Special, Whistler, Being and Greybeard, as well
as CBD brands, Reliva and KG7. Medical cannabis brands include
MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as
well as international brands, Pedanios, Bidiol and CraftPlant.
Aurora also has a controlling interest in Bevo Farms Ltd.,
North America's leading supplier
of propagated agricultural plants. Driven by science and
innovation, and with a focus on high-quality cannabis products,
Aurora's brands continue to break through as industry leaders in
the medical, performance, wellness and adult recreational markets
wherever they are launched. Learn more at www.auroramj.com and
follow us on Twitter and LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB".
Forward-looking Information
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include, but are not limited to, statements with respect to
product innovation and new products to market, competitive
advantages including breeding and genetics and consumer research,
and the expected timing for the release of new products in the
medical and recreational channels.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news
release have been developed based on assumptions
management considers to be reasonable. Material factors
or assumptions involved in developing forward-looking statements
include, without limitation, publicly available information from
governmental sources as well as from market research and industry
analysis and on assumptions based on data and knowledge of this
industry which the Company believes to be reasonable.
Forward-looking statements are subject to a variety of risks,
uncertainties and other factors that management believes to be
relevant and reasonable in the circumstances could cause actual
events, results, level of activity, performance, prospects,
opportunities or achievements to differ materially from those
projected in the forward-looking statements. These risks
include, but are not limited to, the ability to retain key
personnel, the ability to continue investing in infrastructure to
support growth, the ability to obtain financing on acceptable
terms, the continued quality of our products, customer experience
and retention, the development of third party government and
non-government consumer sales channels, management's
estimates of consumer demand in Canada and in jurisdictions where the Company
exports, expectations of future results and expenses, the risk
of successful integration of acquired business and operations,
management's estimation that SG&A will grow only in proportion
of revenue growth, the ability to expand and maintain distribution
capabilities, the impact of competition, the general impact of
financial market conditions, the yield from cannabis growing
operations, product demand, changes in prices of required
commodities, competition, and the possibility for changes in laws,
rules, and regulations in the industry, epidemics, pandemics or
other public health crises, including the current outbreak of
COVID-19, and other risks, uncertainties and factors set out
under the heading "Risk Factors" in the Company's annual
information form dated September 20,
2022 (the "AIF") and filed with Canadian securities
regulators available on the Company's issuer profile on SEDAR
at www.sedar.com and filed with and available on the
SEC's website at www.sec.gov. The Company cautions that
the list of risks, uncertainties and other factors described in the
AIF is not exhaustive and other factors could also adversely affect
its results. Readers are urged to consider the risks, uncertainties
and assumptions carefully in evaluating the forward-looking
statements and are cautioned not to place undue reliance on such
information. The Company is under no obligation, and expressly
disclaims any intention or obligation, to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as expressly required by
applicable securities law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-introduces-fresh-innovation-for-spring-301806181.html
SOURCE Aurora Cannabis Inc.